PT  - JOURNAL ARTICLE
AU  - Wu, Qing
AU  - Xiao, Xiangxue
AU  - Xu, Yingke
TI  - Evaluating the performance of the WHO international reference standard for osteoporosis diagnosis in postmenopausal women of varied polygenic score and race
AID  - 10.1101/2019.12.30.19016154
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2019.12.30.19016154
4099  - http://medrxiv.org/content/early/2020/01/02/2019.12.30.19016154.short
4100  - http://medrxiv.org/content/early/2020/01/02/2019.12.30.19016154.full
AB  - Background Whether the bone mineral density (BMD) T-score performs differently in osteoporosis classification in women of different genetic profiling and race background remains unclear.Methods The genomic data in the Women’s Health Initiative study was analyzed (n=2,417). The polygenic score (PGS) was calculated from 63 BMD-associated single nucleotide polymorphisms (SNPs) for each participant. The World Health Organization’s (WHO) definition of osteoporosis (BMD T-score≤-2.5) was used to estimate the cumulative incidence of fracture.Results T-score classification significantly underestimated the risk of major osteoporotic fracture (MOF) in the WHI study. An enormous underestimation was observed in African American women (POR: 0.52, 95% CI: 0.30-0.83) and in women with low PGS (predicted/observed ratio [POR]: 0.43, 95% CI: 0.28-0.64). Compared to Caucasian women, African American, African Indian, and Hispanic women respectively had a 59%, 41%, and 55% lower hazard of MOF after the T-score was adjusted for. The results were similar when used for any fractures.Conclusions Our study suggested the BMD T-score performance varies significantly by race in postmenopausal women.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by a grant from the National Institute of General Medical Sciences (P20GM121325), a grant from the National Institute on Minority Health and Health Disparities of the National Institutes of Health (R15MD010475).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data/analyses presented in the current publication are based on the use of study data downloaded from the dbGaP web site, under phs000200. https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000200.v12.p3